This compound is a protected phosphoramidite monomer used as a building block in oligonucleotide synthesis. It features a (S)-GNA backbone with a benzoyl-protected cytosine nucleobase and acid-labile dimethoxytrityl (DMT) protecting group.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 885322-06-5
N4-Ac-C-(S)-GNA phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
(S)-GNA-G(iBu) phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
(S)-GNA-A(Bz)-phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
Pharmaceutical intermediate for oligonucleotide synthesis
3'-O-(2-Methoxyethyl)guanosine
Pharmaceutical intermediate for oligonucleotide synthesis
(R)-3-(7-Cyano-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indolin-1-yl)propyl benzoate oxalate
Pharmaceutical intermediate for silodosin analog
((4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)methyl)triphenylphosphonium bromide
Rosuvastatin intermediate
Methyl 6-bromo-1H-indazole-4-carboxylate
Pharmaceutical intermediate
N-[1-[(2S)-3-[bis(4-methoxyphenyl)-phenylmethoxy]-2-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxypropyl]-2-oxopyrimidin-4-yl]benzamide
IQSXGILXOHYNMA-CIMWKYAKSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H](CN1C=CC(=NC1=O)NC(=O)C2=CC=CC=C2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC